Literature DB >> 11313929

The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism.

E Okan1, V Drewett, P E Shaw, P Jones.   

Abstract

The urokinase plasminogen activator receptor (uPAR) focuses extracellular protease activity to the cell surface, modulates cell adhesion and activates intracellular signal transduction pathways. In a range of cancers uPAR expression often has a negative correlation with prognosis. Here we show that uPAR transcription is stimulated by V12 H-Ras, the effector loop mutant V12 H-Ras G37 and constitutively-active RalA 72L. RalA-dependent transcription required the presence of the ATF2-like AP1-site at -70 bp and the c-Jun binding motif at -184 bp in the uPAR promoter. Consistent with this, both Gal4-c-Jun- and Gal4-ATF2-fusion proteins were activated by RalA signalling through phosphorylation of their activation domains at Ser63 and Ser73 of c-Jun or Thr69 and Thr71 of ATF2. A transdominant inhibitory mutant of c-Jun N-terminal kinase (JNK) failed to inhibit uPAR transcription demonstrating that JNK activation is not a prerequisite for RalA-dependent uPAR transcription. A dominant negative inhibitor of c-Src effectively inhibited RalA-dependent uPAR transcription identifying it as a downstream effector in the RalA signalling pathway. These data provide evidence for the existence of a novel signalling pathway that links RalA to the activation of uPAR transcription via a c-Src intermediate and activation of AP1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313929     DOI: 10.1038/sj.onc.1204260

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.

Authors:  Bin Zhang; Wei Shi; Juan Ma; Alexis Sloan; Christian Faul; Changli Wei; Jochen Reiser; Yun Yang; Shuangxin Liu; Wenjian Wang
Journal:  J Mol Med (Berl)       Date:  2012-09-27       Impact factor: 4.599

2.  The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.

Authors:  Nicole F Neel; Timothy D Martin; Jeran K Stratford; Tanya P Zand; David J Reiner; Channing J Der
Journal:  Genes Cancer       Date:  2011-03

3.  Overexpression of Arabidopsis nucleolar GTP-binding 1 (NOG1) proteins confers drought tolerance in rice.

Authors:  Bikram D Pant; Seonghee Lee; Hee-Kyung Lee; Nick Krom; Pooja Pant; YoonJeong Jang; Kirankumar S Mysore
Journal:  Plant Physiol       Date:  2022-06-01       Impact factor: 8.005

4.  Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.

Authors:  Felicia Cooper; Andrew M Overmiller; Anthony Loder; Donna M Brennan-Crispi; Kathleen P McGuinn; Molly R Marous; Theresa A Freeman; Natalia A Riobo-Del Galdo; Linda D Siracusa; James K Wahl; Mỹ G Mahoney
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

5.  Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.

Authors:  D Margriet Ouwens; Nancy D de Ruiter; Gerard C M van der Zon; Andrew P Carter; Jan Schouten; Corina van der Burgt; Klaas Kooistra; Johannes L Bos; J Antonie Maassen; Hans van Dam
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 6.  The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target.

Authors:  Steven Christopher Smith; Dan Theodorescu
Journal:  Urol Oncol       Date:  2009 Jan-Feb       Impact factor: 3.498

7.  Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.

Authors:  Lu Tian; Luqing Zhao; Karen Man-Fong Sze; Charles Shing Kam; Vanessa Sheung-In Ming; Xia Wang; Vanilla Xin Zhang; Daniel Wai-Hung Ho; Tan-To Cheung; Lo-Kong Chan; Irene Oi-Lin Ng
Journal:  Hepatology       Date:  2021-12-17       Impact factor: 17.298

8.  Bisphosphonate inhibits the expression of cyclin A2 at the transcriptional level in normal human oral keratinocytes.

Authors:  Rachel S Lee; Suhjin Sohn; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Int J Mol Med       Date:  2017-07-12       Impact factor: 4.101

9.  Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.

Authors:  Changliang Chen; Anitha K Shenoy; Ravi Padia; Dongdong Fang; Qing Jing; Ping Yang; Shi-Bing Su; Shuang Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-10-03

10.  Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation.

Authors:  Tomoya Iida; Daisuke Hirayama; Naoki Minami; Minoru Matsuura; Kohei Wagatsuma; Kentaro Kawakami; Kanna Nagaishi; Masanori Nojima; Hiroki Ikeuchi; Seiichi Hirota; Ryutaro Shirakawa; Hisanori Horiuchi; Hiroshi Nakase
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.